Jeffrey Robert Friedman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypothalamus | 9 | 2010 | 993 | 0.590 |
Why?
|
| Leptin | 9 | 2011 | 1596 | 0.520 |
Why?
|
| Founder Effect | 4 | 2011 | 185 | 0.360 |
Why?
|
| Neuropeptide Y | 6 | 2007 | 194 | 0.350 |
Why?
|
| Micronesia | 10 | 2010 | 44 | 0.310 |
Why?
|
| Genome, Human | 5 | 2011 | 4448 | 0.310 |
Why?
|
| Neurons | 12 | 2010 | 9525 | 0.300 |
Why?
|
| Pro-Opiomelanocortin | 4 | 2005 | 140 | 0.300 |
Why?
|
| Haplotypes | 5 | 2011 | 2728 | 0.300 |
Why?
|
| Fasting | 4 | 2007 | 1606 | 0.280 |
Why?
|
| Receptors, Neuropeptide | 2 | 2005 | 106 | 0.260 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2005 | 46 | 0.240 |
Why?
|
| Eating | 6 | 2007 | 1540 | 0.240 |
Why?
|
| Hypothalamic Hormones | 1 | 2006 | 146 | 0.240 |
Why?
|
| Microdissection | 1 | 2005 | 152 | 0.240 |
Why?
|
| Pituitary Hormones | 1 | 2006 | 184 | 0.240 |
Why?
|
| Receptors, Cell Surface | 3 | 2001 | 2817 | 0.230 |
Why?
|
| Lasers | 2 | 2005 | 951 | 0.220 |
Why?
|
| Mice, Obese | 9 | 2011 | 417 | 0.220 |
Why?
|
| Receptor, Melanocortin, Type 4 | 5 | 2010 | 132 | 0.220 |
Why?
|
| Melanins | 1 | 2006 | 293 | 0.220 |
Why?
|
| Genetics, Medical | 1 | 2006 | 334 | 0.210 |
Why?
|
| Thinness | 1 | 2006 | 482 | 0.200 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2002 | 85 | 0.190 |
Why?
|
| Receptors, Leptin | 5 | 2010 | 355 | 0.190 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2001 | 25 | 0.180 |
Why?
|
| Microsatellite Repeats | 3 | 2006 | 784 | 0.180 |
Why?
|
| Genetic Linkage | 1 | 2006 | 2341 | 0.170 |
Why?
|
| Energy Metabolism | 4 | 2006 | 2892 | 0.170 |
Why?
|
| Mice, Transgenic | 15 | 2011 | 9550 | 0.170 |
Why?
|
| Chromosome Mapping | 6 | 2011 | 4618 | 0.170 |
Why?
|
| Population Groups | 2 | 2011 | 209 | 0.170 |
Why?
|
| Action Potentials | 2 | 2005 | 1838 | 0.170 |
Why?
|
| Neuronal Plasticity | 2 | 2005 | 1445 | 0.170 |
Why?
|
| Hyperlipidemias | 2 | 2004 | 770 | 0.170 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2000 | 148 | 0.170 |
Why?
|
| Genome-Wide Association Study | 6 | 2011 | 12807 | 0.160 |
Why?
|
| Dyslipidemias | 1 | 2006 | 869 | 0.150 |
Why?
|
| Obesity | 4 | 2006 | 13076 | 0.150 |
Why?
|
| Quantitative Trait Loci | 1 | 2006 | 2140 | 0.140 |
Why?
|
| Nerve Net | 3 | 2006 | 2309 | 0.140 |
Why?
|
| Alleles | 6 | 2011 | 6897 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 6 | 2010 | 2060 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2011 | 16047 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 2 | 2006 | 4392 | 0.130 |
Why?
|
| Weight Loss | 3 | 2011 | 2710 | 0.130 |
Why?
|
| Neurofibromatosis 1 | 1 | 2000 | 560 | 0.120 |
Why?
|
| Receptors, Cytokine | 1 | 1996 | 258 | 0.120 |
Why?
|
| Brain Mapping | 3 | 2005 | 6601 | 0.120 |
Why?
|
| Gene Frequency | 5 | 2011 | 3624 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1996 | 640 | 0.110 |
Why?
|
| Genetics, Population | 2 | 2009 | 943 | 0.110 |
Why?
|
| Carrier Proteins | 5 | 2003 | 4913 | 0.110 |
Why?
|
| Viral Proteins | 1 | 2001 | 1797 | 0.110 |
Why?
|
| Hypertension | 2 | 2006 | 8626 | 0.110 |
Why?
|
| Gene Expression | 6 | 2010 | 7584 | 0.100 |
Why?
|
| Pacific Islands | 2 | 2011 | 52 | 0.100 |
Why?
|
| Crosses, Genetic | 2 | 2006 | 752 | 0.100 |
Why?
|
| Luminescent Proteins | 4 | 2004 | 839 | 0.100 |
Why?
|
| Mice | 22 | 2011 | 81819 | 0.100 |
Why?
|
| Feeding Behavior | 4 | 2011 | 3212 | 0.100 |
Why?
|
| RNA, Messenger | 9 | 2010 | 12768 | 0.100 |
Why?
|
| Proteins | 3 | 2010 | 5995 | 0.100 |
Why?
|
| Pedigree | 3 | 2009 | 4526 | 0.090 |
Why?
|
| Liver | 3 | 2010 | 7562 | 0.090 |
Why?
|
| In Situ Hybridization | 4 | 2010 | 1886 | 0.090 |
Why?
|
| Genotype | 8 | 2011 | 13024 | 0.090 |
Why?
|
| Receptor, Melanocortin, Type 3 | 2 | 2011 | 12 | 0.090 |
Why?
|
| Anticipation, Psychological | 1 | 2011 | 90 | 0.090 |
Why?
|
| Hemoglobins | 1 | 1996 | 1530 | 0.090 |
Why?
|
| Diabetes Mellitus | 2 | 2006 | 5891 | 0.090 |
Why?
|
| Water | 1 | 1996 | 1417 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 4 | 2005 | 918 | 0.090 |
Why?
|
| Receptor, Cholecystokinin A | 1 | 2010 | 13 | 0.090 |
Why?
|
| Nodose Ganglion | 1 | 2010 | 11 | 0.090 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2009 | 361 | 0.080 |
Why?
|
| Gene Pool | 1 | 2009 | 36 | 0.080 |
Why?
|
| Mice, Inbred CBA | 3 | 2009 | 439 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2009 | 18071 | 0.080 |
Why?
|
| Inheritance Patterns | 2 | 2009 | 345 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 10 | 2011 | 22332 | 0.080 |
Why?
|
| Sterols | 1 | 2009 | 63 | 0.080 |
Why?
|
| Vagus Nerve | 2 | 2010 | 460 | 0.080 |
Why?
|
| Sexual Maturation | 1 | 2010 | 246 | 0.080 |
Why?
|
| Phytosterols | 2 | 2009 | 55 | 0.080 |
Why?
|
| Animals | 24 | 2011 | 168764 | 0.080 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2008 | 64 | 0.080 |
Why?
|
| Insulin Resistance | 2 | 2004 | 3985 | 0.070 |
Why?
|
| Motor Activity | 2 | 2011 | 2704 | 0.070 |
Why?
|
| Postprandial Period | 1 | 2010 | 319 | 0.070 |
Why?
|
| Geography | 1 | 2009 | 652 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 11888 | 0.070 |
Why?
|
| Trans-Activators | 1 | 1996 | 2850 | 0.070 |
Why?
|
| Receptors, Melanocortin | 1 | 2006 | 23 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2006 | 3737 | 0.070 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 1 | 2006 | 36 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2005 | 1242 | 0.070 |
Why?
|
| Genetic Variation | 3 | 2011 | 6610 | 0.070 |
Why?
|
| Family Relations | 1 | 2008 | 318 | 0.070 |
Why?
|
| Machado-Joseph Disease | 1 | 2006 | 26 | 0.060 |
Why?
|
| Disease | 1 | 2011 | 676 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 5786 | 0.060 |
Why?
|
| Peptide Hormones | 2 | 2004 | 133 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2009 | 568 | 0.060 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2005 | 45 | 0.060 |
Why?
|
| Thyrotropin | 1 | 2009 | 841 | 0.060 |
Why?
|
| Lipid Metabolism | 2 | 2004 | 1892 | 0.060 |
Why?
|
| Triiodothyronine | 1 | 2007 | 496 | 0.060 |
Why?
|
| Ketone Bodies | 1 | 2004 | 75 | 0.060 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2003 | 125 | 0.060 |
Why?
|
| Linkage Disequilibrium | 2 | 2008 | 1997 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 9601 | 0.060 |
Why?
|
| Enkephalin, Methionine | 1 | 2004 | 26 | 0.060 |
Why?
|
| Brain | 5 | 2009 | 27171 | 0.060 |
Why?
|
| Selection, Genetic | 1 | 2009 | 878 | 0.060 |
Why?
|
| Steroids | 1 | 2009 | 933 | 0.060 |
Why?
|
| Body Weight | 3 | 2004 | 4622 | 0.060 |
Why?
|
| Receptors, Corticotropin | 1 | 2003 | 24 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2009 | 1006 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2005 | 1546 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2008 | 1107 | 0.050 |
Why?
|
| Baclofen | 1 | 2004 | 121 | 0.050 |
Why?
|
| Apolipoprotein A-I | 2 | 2002 | 304 | 0.050 |
Why?
|
| Models, Genetic | 3 | 2009 | 3449 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 4108 | 0.050 |
Why?
|
| Glutamic Acid | 2 | 2005 | 1180 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 1745 | 0.050 |
Why?
|
| Exons | 1 | 2008 | 2391 | 0.050 |
Why?
|
| Microsomes, Liver | 1 | 2002 | 174 | 0.050 |
Why?
|
| Markov Chains | 1 | 2006 | 968 | 0.050 |
Why?
|
| Thermogenesis | 1 | 2007 | 496 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2005 | 752 | 0.050 |
Why?
|
| Electrocardiography | 2 | 2009 | 6404 | 0.050 |
Why?
|
| Ion Channels | 1 | 2007 | 1045 | 0.050 |
Why?
|
| Immunohistochemistry | 4 | 2010 | 11022 | 0.050 |
Why?
|
| Vacuoles | 1 | 2002 | 224 | 0.050 |
Why?
|
| Serotonin | 1 | 2006 | 1049 | 0.050 |
Why?
|
| Lipoproteins, VLDL | 1 | 2002 | 198 | 0.050 |
Why?
|
| Transcription Factors | 3 | 2006 | 12131 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2007 | 975 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2005 | 1134 | 0.040 |
Why?
|
| Insulin | 3 | 2006 | 6599 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2006 | 5783 | 0.040 |
Why?
|
| Heart Murmurs | 1 | 2000 | 92 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 852 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2006 | 1238 | 0.040 |
Why?
|
| Cell Death | 1 | 2006 | 1679 | 0.040 |
Why?
|
| Adipose Tissue | 2 | 2006 | 3312 | 0.040 |
Why?
|
| Male | 19 | 2010 | 363698 | 0.040 |
Why?
|
| Neuropeptides | 1 | 2006 | 951 | 0.040 |
Why?
|
| Neural Inhibition | 1 | 2004 | 589 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2005 | 2669 | 0.040 |
Why?
|
| Noonan Syndrome | 1 | 2000 | 122 | 0.040 |
Why?
|
| Afferent Pathways | 1 | 2001 | 303 | 0.040 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2000 | 164 | 0.040 |
Why?
|
| Body Height | 1 | 2006 | 1562 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2006 | 1118 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2004 | 866 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2006 | 807 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3797 | 0.040 |
Why?
|
| Apolipoproteins B | 1 | 2001 | 384 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2009 | 2247 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 2 | 2009 | 870 | 0.040 |
Why?
|
| Photic Stimulation | 1 | 2005 | 1993 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2008 | 2393 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2006 | 6424 | 0.040 |
Why?
|
| Synapses | 2 | 2005 | 1754 | 0.040 |
Why?
|
| Mitral Valve Prolapse | 1 | 2000 | 213 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2010 | 3085 | 0.040 |
Why?
|
| Integrases | 1 | 2001 | 520 | 0.040 |
Why?
|
| Aortic Coarctation | 1 | 2000 | 277 | 0.040 |
Why?
|
| Female | 17 | 2010 | 396112 | 0.040 |
Why?
|
| Energy Intake | 1 | 2006 | 2141 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2001 | 999 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4562 | 0.040 |
Why?
|
| Mice, Knockout | 4 | 2007 | 14448 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2011 | 6255 | 0.040 |
Why?
|
| Heart Rate | 1 | 2009 | 4204 | 0.030 |
Why?
|
| Lipoprotein Lipase | 1 | 1997 | 132 | 0.030 |
Why?
|
| Bivalvia | 1 | 1996 | 54 | 0.030 |
Why?
|
| Sequence Tagged Sites | 1 | 1996 | 96 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2001 | 12240 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2003 | 17594 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 1525 | 0.030 |
Why?
|
| Phylogeny | 3 | 2009 | 2832 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2002 | 1870 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2005 | 2428 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2003 | 1341 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 1996 | 425 | 0.030 |
Why?
|
| Dimerization | 1 | 1996 | 880 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2002 | 2927 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2006 | 2968 | 0.030 |
Why?
|
| Agouti-Related Protein | 2 | 2007 | 95 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2002 | 2195 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2005 | 5881 | 0.030 |
Why?
|
| Syndrome | 1 | 2000 | 3271 | 0.030 |
Why?
|
| Body Composition | 1 | 2003 | 2439 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 1679 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 2900 | 0.030 |
Why?
|
| Virus Replication | 1 | 2001 | 2447 | 0.030 |
Why?
|
| Humans | 19 | 2011 | 765968 | 0.030 |
Why?
|
| Triglycerides | 1 | 2001 | 2441 | 0.030 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 2 | 2003 | 122 | 0.030 |
Why?
|
| Base Sequence | 2 | 2010 | 12403 | 0.030 |
Why?
|
| DNA Primers | 1 | 1996 | 2825 | 0.020 |
Why?
|
| Homeostasis | 1 | 2003 | 3336 | 0.020 |
Why?
|
| Ghrelin | 2 | 2004 | 255 | 0.020 |
Why?
|
| Cholesterol | 1 | 2001 | 2898 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2011 | 227 | 0.020 |
Why?
|
| Lipids | 1 | 2002 | 3315 | 0.020 |
Why?
|
| Tetracycline | 1 | 2011 | 216 | 0.020 |
Why?
|
| tau Proteins | 1 | 2001 | 2112 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2005 | 2266 | 0.020 |
Why?
|
| Time Factors | 4 | 2011 | 40065 | 0.020 |
Why?
|
| Fatty Acids | 1 | 1997 | 1806 | 0.020 |
Why?
|
| Photomicrography | 1 | 2009 | 72 | 0.020 |
Why?
|
| Computer Graphics | 1 | 2011 | 344 | 0.020 |
Why?
|
| Lac Operon | 1 | 2009 | 238 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2009 | 163 | 0.020 |
Why?
|
| Nervous System | 1 | 2011 | 542 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2009 | 365 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2007 | 1657 | 0.020 |
Why?
|
| Physical Conditioning, Animal | 1 | 2011 | 366 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2009 | 334 | 0.020 |
Why?
|
| Guanosine Diphosphate | 1 | 2007 | 79 | 0.020 |
Why?
|
| Cricetulus | 1 | 2008 | 805 | 0.020 |
Why?
|
| Consanguinity | 1 | 2008 | 460 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 2006 | 244 | 0.020 |
Why?
|
| Serotonin 5-HT1 Receptor Agonists | 1 | 2006 | 42 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 9525 | 0.020 |
Why?
|
| Fertility | 1 | 2010 | 768 | 0.020 |
Why?
|
| CHO Cells | 1 | 2008 | 1372 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2009 | 677 | 0.020 |
Why?
|
| Algorithms | 3 | 2011 | 14071 | 0.020 |
Why?
|
| RNA, Complementary | 1 | 2005 | 46 | 0.020 |
Why?
|
| Software | 2 | 2009 | 4462 | 0.020 |
Why?
|
| Mutation | 3 | 2009 | 30198 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 1823 | 0.020 |
Why?
|
| Iodide Peroxidase | 1 | 2007 | 297 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2001 | 8532 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2004 | 64 | 0.010 |
Why?
|
| Rhombencephalon | 1 | 2005 | 81 | 0.010 |
Why?
|
| Cricetinae | 1 | 2008 | 2411 | 0.010 |
Why?
|
| Appetite Regulation | 1 | 2005 | 84 | 0.010 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2004 | 135 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 869 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2007 | 576 | 0.010 |
Why?
|
| Gastrointestinal Tract | 1 | 2010 | 834 | 0.010 |
Why?
|
| Homozygote | 1 | 2008 | 1775 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2009 | 1158 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2004 | 287 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2009 | 2601 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 2004 | 244 | 0.010 |
Why?
|
| Prosencephalon | 1 | 2005 | 305 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 463 | 0.010 |
Why?
|
| Europe | 1 | 2009 | 3423 | 0.010 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2002 | 28 | 0.010 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2004 | 366 | 0.010 |
Why?
|
| Apolipoprotein A-II | 1 | 2002 | 41 | 0.010 |
Why?
|
| Mitochondria | 2 | 2007 | 3673 | 0.010 |
Why?
|
| DNA | 2 | 2009 | 7202 | 0.010 |
Why?
|
| Medulla Oblongata | 1 | 2003 | 246 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2004 | 402 | 0.010 |
Why?
|
| Phenotype | 2 | 2010 | 16721 | 0.010 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2002 | 111 | 0.010 |
Why?
|
| Genome | 1 | 2009 | 1753 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2006 | 1735 | 0.010 |
Why?
|
| Neuroglia | 1 | 2007 | 964 | 0.010 |
Why?
|
| Presynaptic Terminals | 1 | 2003 | 297 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2010 | 23601 | 0.010 |
Why?
|
| Transfection | 1 | 2008 | 5743 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2008 | 2599 | 0.010 |
Why?
|
| Transgenes | 1 | 2004 | 1015 | 0.010 |
Why?
|
| Lipase | 1 | 2002 | 320 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2003 | 2171 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 2505 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 2218 | 0.010 |
Why?
|
| Computational Biology | 1 | 2010 | 3559 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 1965 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 2004 | 1048 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2000 | 42500 | 0.010 |
Why?
|
| Rats | 2 | 2005 | 23707 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2004 | 1140 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2004 | 1624 | 0.010 |
Why?
|
| Family Health | 1 | 2002 | 1253 | 0.010 |
Why?
|
| Risk Factors | 2 | 2002 | 74840 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2002 | 1458 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2002 | 15652 | 0.010 |
Why?
|
| Adult | 4 | 2009 | 223044 | 0.010 |
Why?
|
| Ligands | 1 | 2003 | 3273 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2004 | 2867 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 2086 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 6001 | 0.010 |
Why?
|
| Pyridines | 1 | 2006 | 2888 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 8102 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 8278 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 20124 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14652 | 0.010 |
Why?
|
| Middle Aged | 3 | 2004 | 223009 | 0.010 |
Why?
|
| Biological Transport | 1 | 1997 | 2081 | 0.010 |
Why?
|
| Glucose | 1 | 2004 | 4335 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1997 | 1167 | 0.010 |
Why?
|
| Child | 1 | 2000 | 80564 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 13400 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 4247 | 0.010 |
Why?
|
| Prevalence | 1 | 2009 | 15842 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 7599 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 9296 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 41649 | 0.000 |
Why?
|
| Pregnancy | 1 | 2010 | 30260 | 0.000 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 17075 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 2004 | 59489 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 2003 | 7851 | 0.000 |
Why?
|
| Diet | 1 | 2004 | 8086 | 0.000 |
Why?
|
| Aged | 2 | 2004 | 171117 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2009 | 81514 | 0.000 |
Why?
|